MTOR and age-related macular degeneration: An inhibitor experiment was conducted using rapamycin, a strong inhibitor of mTOR phosphorylation, to investigate whether pretreatment with AMD had a protective effect against METH-induced neurotoxicity via the mTOR signaling pathway.